This stock has baggage. Anything short of FDA approval won't move this. Looks more and more like something you flip on 5-10% action or hold for years with the understanding that there will be a big RS at some point, and any BIG money to be made will have to have a huge position and wait 2+ years. I'm out as soon as this sniffs .06 if it ever does again before the RS. I don't doubt the products and I think Fred Colen is no dummy. But he stepped into a tough position and I (like a TON of others) hoped this would have a little more action by now. I am seeing it with my other biotech stock: Pulmatrix- great clinical data, but the market doesn't care. Far from FDA approval, individual investors giving up. Biotech penny stocks...pretty standard I suppose.
News 
Market Data 
Discover 
